Namenda (Memantine) – Patient Information (UK)

Namenda contains memantine, a medicine used for certain types of dementia. This guide explains what Namenda is, how it works, how it’s usually taken, what to expect, and important safety information for people in the United Kingdom.

Important: This information is for general guidance and does not replace advice from your doctor or pharmacist. If you have questions about your personal situation, ask a healthcare professional.

Basic product information

• Active ingredient: Memantine (as memantine hydrochloride)
• Brand name: Namenda
• Medicine type: Dementia medicine (NMDA receptor antagonist)
• Common strengths (may vary by manufacturer/formulation): Often available as tablets of different strengths (e.g., 5 mg, 10 mg, 15 mg, 20 mg) depending on the brand and formulation in the UK
• How it is taken: By mouth

In the UK, medicines for dementia are typically used alongside supportive care (family support, routine, cognition-friendly activities, and managing other health conditions).

What is dementia and why might memantine be used?

Dementia is a general term for a decline in memory and other thinking abilities severe enough to affect everyday life. Alzheimer’s disease is the most common cause, but dementia can also arise from other conditions.

Namenda (memantine) is used for people with moderate to severe Alzheimer’s disease. It aims to help maintain daily function and reduce certain symptoms related to the condition.

How Namenda works (mechanism of action)

Memantine works by affecting signalling in the brain. In particular, it blocks NMDA (N-methyl-D-aspartate) receptors, which are involved in learning, memory, and communication between brain cells.

In Alzheimer’s disease and related dementias, excessive activation of NMDA receptors may contribute to damage and symptoms. By regulating this signalling, memantine may help:

• Support brain function
• Improve or stabilise symptoms such as thinking ability and behaviour for some people
• Maintain activities of daily living for longer in some patients

Key point: Namenda does not cure dementia. Its effects are usually gradual and may be modest.

Pharmacokinetics: how the body handles memantine

Pharmacokinetics describes how a medicine is absorbed, distributed, broken down, and eliminated.

• Absorption: Memantine is absorbed after taking by mouth.
• Distribution: It reaches the brain and central nervous system to exert its effects.
• Metabolism: A relatively small amount is metabolised by the body.
• Elimination: Memantine is cleared mainly by the kidneys (urine). This makes kidney function important for dosing.
• Half-life (general idea): Memantine has a long enough duration of action that it is typically taken once daily, depending on the regimen and formulation.

Why kidney function matters: If kidney function is reduced, memantine may build up more easily. Your clinician may adjust the dose accordingly.

Typical use and indications in the UK

Namenda is used for the symptomatic treatment of moderate to severe Alzheimer’s disease in adults.

It is intended to help manage symptoms and support day-to-day functioning. Some people may notice benefit, while others may experience little change. However, treatment may still be worthwhile as it can help maintain function for longer in some cases.

How to take Namenda: dosing and timing

Dosing must be individualised. The most common approach is to start low and gradually increase to reduce side effects. Your prescriber or pharmacist will provide a schedule based on your needs, age, and kidney function.

Common titration approach (general pattern)

In many memantine regimens, treatment begins at a low dose and is increased stepwise over several weeks until a maintenance dose is reached.

• Start low to allow the body to adjust
• Increase gradually over time
• Use the maintenance dose once the target is reached

Note: Exact dosing depends on the formulation and the dose strength available. Always follow the instructions on your label or medication plan.

When to take it

• Once daily is common for many formulations in UK practice.
• Choose a consistent time each day to help adherence.
• If you are sensitive to side effects, your clinician may advise taking it at a specific time of day.

What if you miss a dose?

• If you miss a dose, take it when you remember if it is not close to the next dose.
• If it is almost time for the next dose, skip the missed dose.
• Do not take a double dose.

Stopping treatment

Do not stop memantine suddenly without medical advice. If stopping is needed, clinicians may advise a plan to reduce risk of worsening symptoms.

Food interactions and dietary considerations

Memantine can generally be taken with or without food. Food is not usually expected to dramatically affect absorption.

However, practical points can still help:

• If gastrointestinal discomfort occurs, taking it with food may help.
• Keep the dosing routine consistent (same time each day).

Hydration and urinary pH: Because elimination is through the kidneys, conditions that strongly alter urine chemistry may theoretically affect memantine levels. Avoid drastic changes without advice.

Alcohol and medicine interactions

Alcohol: There is no specific “safe level” for alcohol with dementia medicines. Alcohol can worsen confusion, balance, sleep, and overall safety—particularly in older adults or people with memory problems. If you choose to drink alcohol, do so cautiously and discuss with your clinician or pharmacist.

General medicine interactions: Memantine may interact with other medicines that affect the central nervous system (brain activity) or those that influence kidney function and urine pH.

Medicines that may be relevant to discuss

• Other dementia medicines (e.g., donepezil, rivastigmine, galantamine): can sometimes be used together under supervision; your clinician will consider benefits and side effects.
• Medicines affecting NMDA receptors or those with strong effects on the brain: may increase risk of side effects.
• Medicines that change urine pH, such as some alkalinising or acidifying agents: these can influence how memantine is handled by the kidneys.
• Medicines cleared by the kidneys or those that compete for elimination: may require closer monitoring.

Important: Always tell your pharmacist about all medicines you take, including over-the-counter products and supplements.

Safety profile: common and important side effects

Like all medicines, Namenda can cause side effects. Many people tolerate it well, but careful monitoring is important, especially during dose increases.

Common side effects (examples)

• Dizziness
• Headache
• Constipation
• Confusion (may be difficult to distinguish from dementia symptoms)
• Sleepiness or tiredness

Less common but important

• Falls (especially if dizziness or sleepiness occurs)
• Unsteadiness
• Signs of allergic reaction (e.g., rash, swelling, difficulty breathing)

Seek urgent medical advice if

• You suspect an allergic reaction
• There are severe or rapidly worsening symptoms
• There are signs of serious illness such as severe confusion beyond baseline, fainting, or severe shortness of breath

Special safety considerations

• Kidney problems: may require dose reduction and closer monitoring.
• Older age: increased sensitivity to dizziness and falls—monitor closely, especially after dose increases.
• Driving and machinery: memantine can cause dizziness or sleepiness in some people. Avoid driving and risky tasks if affected.

Practical use tips (for patients and carers)

Dementia care works best when medication routines are simple, predictable, and safe. Here are practical suggestions:

• Use a medication organiser (weekly blister or pillbox) to reduce missed or repeated doses.
• Choose a consistent time each day; links to an existing routine (e.g., breakfast) can help.
• Keep track of side effects, especially during dose titration (e.g., dizziness, constipation, sleep changes).
• Prevent constipation with hydration, fibre, and movement where possible; ask a pharmacist if constipation becomes persistent.
• Monitor falls risk: ensure adequate lighting, remove trip hazards, and encourage slow position changes (sitting before standing).
• Hydration: encourage regular fluids unless you have been advised to restrict fluids for another medical reason.
• Review medicines regularly: dementia patients often take multiple medicines, increasing interaction risk.

If someone else assists with the medicines, consider writing down:

• Date started and dose schedule
• Any side effects observed
• Upcoming appointments for medication review

Alternative options (what else might be considered)

Your clinician may consider several approaches depending on the type and stage of dementia, other health conditions, and individual goals.

Other medication options

• Cholinesterase inhibitors (for mild to moderate Alzheimer’s disease; may be used in selected patients): donepezil, rivastigmine, galantamine.
• Combination approaches: in some cases, memantine may be used alongside a cholinesterase inhibitor if clinically appropriate.

Non-medicine support (often essential)

• Structured routines and memory-friendly strategies
• Hearing and vision checks (to reduce confusion)
• Physiotherapy and safe physical activity
• Support for caregivers (training, respite, advice on behaviour management)
• Treating contributing factors such as infection, pain, depression, constipation, or sleep problems

Note: The right choice varies widely between individuals. Ask your clinician what alternatives fit your specific needs.

Market and legal context in the United Kingdom

In the UK, dementia medicines are regulated medicines. Availability can depend on the product and formulation and must be supplied according to current UK medicine regulations and pharmacy requirements.

Within the NHS and local care pathways, dementia treatment is typically initiated and reviewed by healthcare professionals experienced in dementia care. Ongoing monitoring helps confirm benefit and manage side effects.

Summary of the UK approach:

• Use is based on clinical diagnosis and severity (e.g., moderate to severe Alzheimer’s disease).
• Dosing is adjusted for tolerability and kidney function.
• Regular review supports continued use if benefits are present.
• Care plans often combine medication with non-drug strategies.

Recent guidance and quality-of-care focus

For dementia treatment, UK practice commonly emphasises:

• Clear diagnostic basis and appropriate severity grading
• Baseline assessment and follow-up to evaluate benefit
• Shared decision-making with people with dementia and carers where possible
• Medication reviews, including looking for interactions and adverse effects
• Holistic care: addressing pain, sleep, infection, mental health, constipation, and behavioural symptoms

While recommendations can evolve, the overall UK emphasis remains on safe prescribing, monitoring, and integrating medication with comprehensive dementia support.

Delivery and availability (UK)

Availability of Namenda (memantine) may vary by formulation (tablet strengths, extended-release options where applicable) and supplier. When ordering online, ensure you select the correct strength and formulation as advised by your clinician.

What to expect

• Check product details before ordering (strength, pack size, and dosage form).
• Delivery times may vary depending on location and stock availability.
• Cold or temperature-controlled storage is usually not required for memantine, but follow storage instructions on the packaging.

Tip: If you are near the end of your supply, consider ordering early to avoid missed doses during holidays or busy periods.

Dosing overview (table)

Frequently Asked Questions (FAQ)

1) Is Namenda the same as memantine?

Yes. Namenda is a brand name that contains memantine.

2) When should I expect any benefit?

Changes, if they happen, are typically gradual. Some people notice improvement or stabilisation over weeks to months. Regular review helps determine whether treatment is working for you.

3) Can Namenda be taken with other dementia medicines?

In some situations, memantine may be used with other dementia medicines (such as cholinesterase inhibitors). This should be guided by your clinician, based on your diagnosis, stage of dementia, and side effect profile.

4) Can I take it with meals?

Usually yes—memantine can be taken with or without food. Choose a routine that is easiest to follow, and take it consistently.

5) Does alcohol affect Namenda?

Alcohol may worsen confusion and increase fall risk. If you drink alcohol, do so carefully and discuss your situation with your healthcare professional—especially if you or your relative is unsteady or drowsy.

6) What should I do if the person I care for becomes more confused after starting memantine?

Some confusion can overlap with dementia progression or other factors. Contact a healthcare professional to discuss symptoms promptly, especially after dose changes. Do not stop or adjust the dose without advice.

7) What are the most important interactions to know about?

Tell your pharmacist about all medicines and supplements. Interactions can involve drugs that affect the brain, those cleared through the kidneys, and medicines that alter urine pH. Your pharmacist can check your medication list for safety.

8) Can memantine be taken if someone has kidney problems?

It may be possible, but dose adjustment and closer monitoring are often needed. Always seek personalised advice based on kidney function results.

9) Are there driving or safety concerns?

If memantine causes dizziness or sleepiness, it may affect driving and safe decision-making. Use caution and follow local safety guidance. If there is any doubt, avoid driving and seek advice.

10) What if we run out before the next supply arrives?

Try to avoid missed doses by ordering early. If you do miss a dose, follow the missed-dose guidance and contact your pharmacist if you are unsure.

Key takeaways

• Namenda (memantine) is used for symptomatic treatment of moderate to severe Alzheimer’s disease.
• It works by regulating NMDA receptor activity in the brain.
• Dosing is typically started low and increased gradually to improve tolerability.
• Kidney function is important because memantine is eliminated mainly via the urine.
• Watch for side effects such as dizziness and constipation, and reduce fall risk during dose changes.
• Regular clinical review helps ensure the medicine continues to provide benefit and remains safe.

If you have questions about whether Namenda is suitable for you, or if you’re unsure about dose timing or side effects, speak to a qualified healthcare professional or pharmacist.